Erin Wright
Stock Analyst at Morgan Stanley
(4.49)
# 309
Out of 5,124 analysts
246
Total ratings
64.37%
Success rate
14.29%
Average return
Main Sectors:
Stocks Rated by Erin Wright
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HUM Humana | Maintains: Equal-Weight | $277 → $262 | $256.13 | +2.29% | 5 | Dec 18, 2025 | |
| ELV Elevance Health | Maintains: Equal-Weight | $359 → $352 | $350.55 | +0.41% | 5 | Dec 18, 2025 | |
| ELAN Elanco Animal Health | Maintains: Equal-Weight | $18 → $22 | $22.63 | -2.78% | 12 | Dec 18, 2025 | |
| CVS CVS Health | Maintains: Overweight | $89 → $93 | $79.36 | +17.19% | 7 | Dec 10, 2025 | |
| ZTS Zoetis | Maintains: Overweight | $211 → $175 | $125.82 | +39.09% | 8 | Nov 10, 2025 | |
| MCK McKesson | Maintains: Overweight | $857 → $916 | $820.29 | +11.67% | 10 | Nov 6, 2025 | |
| HSIC Henry Schein | Maintains: Underweight | $55 → $58 | $75.58 | -23.26% | 5 | Nov 5, 2025 | |
| IDXX IDEXX Laboratories | Maintains: Overweight | $765 → $805 | $676.53 | +18.99% | 19 | Nov 4, 2025 | |
| ALGN Align Technology | Maintains: Equal-Weight | $142 → $154 | $156.15 | -1.38% | 25 | Oct 30, 2025 | |
| OPCH Option Care Health | Initiates: Overweight | $35 | $31.86 | +9.86% | 1 | Oct 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $163 → $204 | $173.54 | +17.55% | 3 | Oct 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $25 → $32 | $37.45 | -14.55% | 4 | Oct 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $128 → $140 | $129.04 | +8.49% | 2 | Oct 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $16 → $17 | $21.71 | -21.70% | 9 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $313 → $330 | $337.75 | -2.29% | 1 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $181 → $190 | $205.50 | -7.54% | 12 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $21 → $26 | $37.36 | -30.41% | 23 | Jun 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $379 → $390 | $275.23 | +41.70% | 5 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $3.5 → $3.2 | $3.20 | - | 12 | Apr 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $30 → $23 | $11.43 | +101.22% | 12 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $145 → $172 | $173.53 | -0.88% | 5 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $587 | $330.11 | +77.82% | 3 | Jul 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Overweight | $300 | $250.88 | +19.58% | 4 | Aug 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $39 → $42 | $11.46 | +266.49% | 5 | Jul 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $282 → $288 | $228.92 | +25.81% | 6 | Jun 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $342 → $352 | $199.48 | +76.46% | 4 | May 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $42 → $44 | $3.25 | +1,253.85% | 2 | May 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $178 → $181 | $561.65 | -67.77% | 8 | Mar 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $14 → $17 | $66.55 | -74.46% | 6 | Feb 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $104 → $121 | $33.05 | +266.11% | 7 | Jan 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $556 → $580 | $579.45 | +0.09% | 4 | Jan 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $35 | $8.81 | +297.28% | 1 | Jan 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $181 → $205 | $182.22 | +12.50% | 2 | Jul 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $12 → $11 | $26.27 | -58.13% | 6 | May 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $175 → $157 | $225.41 | -30.35% | 1 | Apr 2, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underperform | $31 → $17 | $2.80 | +507.14% | 1 | Nov 20, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $300 → $308 | $483.67 | -36.32% | 1 | Oct 25, 2017 |
Humana
Dec 18, 2025
Maintains: Equal-Weight
Price Target: $277 → $262
Current: $256.13
Upside: +2.29%
Elevance Health
Dec 18, 2025
Maintains: Equal-Weight
Price Target: $359 → $352
Current: $350.55
Upside: +0.41%
Elanco Animal Health
Dec 18, 2025
Maintains: Equal-Weight
Price Target: $18 → $22
Current: $22.63
Upside: -2.78%
CVS Health
Dec 10, 2025
Maintains: Overweight
Price Target: $89 → $93
Current: $79.36
Upside: +17.19%
Zoetis
Nov 10, 2025
Maintains: Overweight
Price Target: $211 → $175
Current: $125.82
Upside: +39.09%
McKesson
Nov 6, 2025
Maintains: Overweight
Price Target: $857 → $916
Current: $820.29
Upside: +11.67%
Henry Schein
Nov 5, 2025
Maintains: Underweight
Price Target: $55 → $58
Current: $75.58
Upside: -23.26%
IDEXX Laboratories
Nov 4, 2025
Maintains: Overweight
Price Target: $765 → $805
Current: $676.53
Upside: +18.99%
Align Technology
Oct 30, 2025
Maintains: Equal-Weight
Price Target: $142 → $154
Current: $156.15
Upside: -1.38%
Option Care Health
Oct 17, 2025
Initiates: Overweight
Price Target: $35
Current: $31.86
Upside: +9.86%
Oct 14, 2025
Maintains: Equal-Weight
Price Target: $163 → $204
Current: $173.54
Upside: +17.55%
Oct 14, 2025
Maintains: Overweight
Price Target: $25 → $32
Current: $37.45
Upside: -14.55%
Oct 3, 2025
Maintains: Equal-Weight
Price Target: $128 → $140
Current: $129.04
Upside: +8.49%
Aug 1, 2025
Maintains: Equal-Weight
Price Target: $16 → $17
Current: $21.71
Upside: -21.70%
Jul 16, 2025
Maintains: Equal-Weight
Price Target: $313 → $330
Current: $337.75
Upside: -2.29%
Jul 16, 2025
Maintains: Overweight
Price Target: $181 → $190
Current: $205.50
Upside: -7.54%
Jun 25, 2025
Maintains: Equal-Weight
Price Target: $21 → $26
Current: $37.36
Upside: -30.41%
May 5, 2025
Maintains: Overweight
Price Target: $379 → $390
Current: $275.23
Upside: +41.70%
Apr 17, 2025
Maintains: Underweight
Price Target: $3.5 → $3.2
Current: $3.20
Upside: -
Dec 17, 2024
Maintains: Overweight
Price Target: $30 → $23
Current: $11.43
Upside: +101.22%
Dec 17, 2024
Upgrades: Overweight
Price Target: $145 → $172
Current: $173.53
Upside: -0.88%
Jul 14, 2023
Reiterates: Overweight
Price Target: $587
Current: $330.11
Upside: +77.82%
Aug 22, 2022
Assumes: Overweight
Price Target: $300
Current: $250.88
Upside: +19.58%
Jul 30, 2021
Maintains: Outperform
Price Target: $39 → $42
Current: $11.46
Upside: +266.49%
Jun 18, 2021
Maintains: Outperform
Price Target: $282 → $288
Current: $228.92
Upside: +25.81%
May 28, 2021
Maintains: Neutral
Price Target: $342 → $352
Current: $199.48
Upside: +76.46%
May 11, 2021
Maintains: Outperform
Price Target: $42 → $44
Current: $3.25
Upside: +1,253.85%
Mar 17, 2021
Maintains: Outperform
Price Target: $178 → $181
Current: $561.65
Upside: -67.77%
Feb 26, 2021
Maintains: Neutral
Price Target: $14 → $17
Current: $66.55
Upside: -74.46%
Jan 13, 2021
Maintains: Outperform
Price Target: $104 → $121
Current: $33.05
Upside: +266.11%
Jan 12, 2021
Maintains: Outperform
Price Target: $556 → $580
Current: $579.45
Upside: +0.09%
Jan 5, 2021
Initiates: Neutral
Price Target: $35
Current: $8.81
Upside: +297.28%
Jul 23, 2020
Maintains: Outperform
Price Target: $181 → $205
Current: $182.22
Upside: +12.50%
May 5, 2020
Maintains: Neutral
Price Target: $12 → $11
Current: $26.27
Upside: -58.13%
Apr 2, 2020
Maintains: Outperform
Price Target: $175 → $157
Current: $225.41
Upside: -30.35%
Nov 20, 2017
Maintains: Underperform
Price Target: $31 → $17
Current: $2.80
Upside: +507.14%
Oct 25, 2017
Maintains: Neutral
Price Target: $300 → $308
Current: $483.67
Upside: -36.32%